Postes actifs de Alexey Wolfson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MirImmune, Inc.
 MirImmune, Inc. BiotechnologyHealth Technology MirImmune, Inc. is a biopharmaceutical company that develops new generation immunotherapies for cancer. It combines two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies. The company was founded by Alexey V. Eliseev, Alexey Wolfson, and Timothy Joseph Barberich on May 18, 2015 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | - | - |
| Fondateur | 18/05/2015 | - | |
| Secrétaire Général | - | - | |
| Directeur Technique/Scientifique/R&D | 18/05/2015 | - | |
Advirna LLC
 Advirna LLC BiotechnologyHealth Technology Advirna LLC engages in the development of new nucleic-based technologies for therapeutic and research use. It offers validated self-deliverable ribonucleic acid (SDRNA), in vivo SDRNA, transfection controls, starter kits, and custom SDRNA. The company was founded by Anastasia Khvorova and Alexey Wolfson in 2007 and is headquartered in Worcester, MA. | Directeur Général | 01/01/2007 | - |
| Fondateur | 01/01/2007 | - |
Historique de carrière de Alexey Wolfson
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MirImmune, Inc.
MirImmune, Inc. BiotechnologyHealth Technology MirImmune, Inc. is a biopharmaceutical company that develops new generation immunotherapies for cancer. It combines two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies. The company was founded by Alexey V. Eliseev, Alexey Wolfson, and Timothy Joseph Barberich on May 18, 2015 and is headquartered in Boston, MA. | Health Technology |
Advirna LLC
Advirna LLC BiotechnologyHealth Technology Advirna LLC engages in the development of new nucleic-based technologies for therapeutic and research use. It offers validated self-deliverable ribonucleic acid (SDRNA), in vivo SDRNA, transfection controls, starter kits, and custom SDRNA. The company was founded by Anastasia Khvorova and Alexey Wolfson in 2007 and is headquartered in Worcester, MA. | Health Technology |
- Bourse
- Insiders
- Alexey Wolfson
- Expérience
